Evaluation of minimally invasive, ultrasound-guided synovial biopsy techniques by the OMERACT filter - Determining validation requirements

Journal of Rheumatology

Volumn 43, Issue 1, 2016, Pages 208-213

  Humby, Frances ^a   Kelly, Stephen ^a   Bugatti, Serena ^b   Manzo, Antonio ^b   Filer, Andrew ^c   Mahto, Arti ^a   Fonseca, Joao Eurico ^e   Lauwerys, Bernard ^f   D'Agostino, Maria Antonietta ^g   Naredo, Esperanza ^h   Lories, Rik ⁱ   Montecucco, Carlomaurizio ^b   Tak, Paul Peter ^j,k   Fitzgerald, Oliver ^l   Smith, Malcolm D ^m   Veale, Douglas J ^l   Choy, Ernest H ⁿ   Strand, Vibeke ^d   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g INSERM U 987   (France)

^h HOSPITAL SEVERO OCHOA   (Spain)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k GLAXOSMITHKLINE   (United Kingdom)

^l ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^m REPATRIATION GENERAL HOSPITAL   (Australia)

ⁿ CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

more..

Author keywords

Rheumatoid arthritis ultrasound; Synovitis biopsy

Indexed keywords

ARTHROSCOPY; ARTICLE; CLINICAL EVALUATION; ECHOGRAPHY; FEASIBILITY STUDY; HUMAN; IMAGE GUIDED BIOPSY; JOINT BIOPSY; KNEE; METACARPOPHALANGEAL JOINT; MINIMALLY INVASIVE PROCEDURE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SYNOVITIS; SYNOVIUM; VALIDATION STUDY; ARTHRITIS, RHEUMATOID; DIAGNOSTIC IMAGING; DOPPLER ULTRASONOGRAPHY; EVALUATION STUDY; FEMALE; MALE; MINIMALLY INVASIVE SURGERY; PATHOLOGY; PATIENT SAFETY; PRACTICE GUIDELINE; PROCEDURES; SEVERITY OF ILLNESS INDEX; STANDARDS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENT;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; MALE; MINIMALLY INVASIVE SURGICAL PROCEDURES; PATIENT SAFETY; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; SYNOVIAL MEMBRANE; SYNOVITIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 84983514615     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141199     Document Type: Article

References (37)

1. Schoels M, Knevel R, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas DT, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 2010; 69:638-43.
2. Breedveld FC, Combe B. Understanding emerging treatment paradigms in rheumatoid arthritis. Arthritis Res Ther 2011; 13:S3.
3. Choy EH, Kavanaugh AF, Jones SA. The problem of choice: current biologic agents and future prospects in RA. Nat Rev Rheumatol 2013; 9:154-63.
4. Sekiguchi N, Kawauchi S, Furuya T, Inaba N, Matsuda K, Ando S, et al. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab. Rheumatology 2008; 47:780-8.
5. Lequerre T, Gauthier-Jauneau AC, Bansard C, Derambure C, Hiron M, Vittecoq O, et al. Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther 2006; 8:R105.
6. Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, Kekow J, et al. Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept. Arthritis Res Ther 2008; 10:R50.
7. Marotte H, Maslinski W, Miossec P. Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response. Arthritis Res Ther 2005; 7:R149-55.
8. Lindberg J, Wijbrandts CA, van Baarsen LG, Nader G, Klareskog L, Catrina A, et al. The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis. PloS One 2010; 5:e11310.
9. Dennis G, Holweg C, Kummerfeld S, Choy D, Setiadi F, Hackney J, et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther 2014; 16:R90.
10. Pitzalis C, Kelly S, Humby F. New learnings on the pathophysiology of RA from synovial biopsies. Current Opin Rheumatol 2013; 25:334-44.
11. Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 2014; 14:447-62.
12. Wechalekar M, Smith M. Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states. World J Orthop 2014; 5:1-8.
13. Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, et al. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium. Ann Rheum Dis 2008; 67:1139-44.
14. van de Sande MG, Gerlag DM, Lodde BM, van Baarsen LG, Alivernini S, Codullo V, et al. Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials. Ann Rheum Dis 2011; 70:423-7.
15. Bresnihan B, Baeten D, Firestein GS, Fitzgerald OM, Gerlag DM, Haringman JJ, et al. Synovial tissue analysis in clinical trials. J Rheumatol 2005; 32:2481-4.
16. de Hair MJ, Harty LC, Gerlag DM, Pitzalis C, Veale DJ, Tak PP. Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritis. J Rheumatol 2011; 38:2068-72.
17. Gerlag D, Tak PP. Synovial biopsy. Best Prac Res Clin Rheumatol 2005; 19:387-400.
18. Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol 1999; 18:434-41.
19. Kane D, Veale DJ, FitzGerald O, Reece R. Survey of arthroscopy performed by rheumatologists. Rheumatology 2002; 41:210-5.
20. van de Sande MG, de Hair MJ, van der Leij C, Klarenbeek PL, Bos WH, Smith MD, et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2011; 70:772-7.
21. Smith MD, Baeten D, Ulfgren AK, McInnes IB, Fitzgerald O, Bresnihan B, et al. Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go? Ann Rheum Dis 2006; 65:93-100.
22. van Steenbergen HW, van Nies JA, Huizinga TW, Bloem JL, Reijnierse M, van der Helm-van Mil AH. Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI. Ann Rheum Dis 2014 April 9 (E-pub ahead of print).
23. Linn-Rasker SP, van der Helm-van Mil AH, Breedveld FC, Huizinga TW. Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis. Ann Rheum Dis 2007; 66:646-50.
24. Veale DJ. The role of arthroscopy in early arthritis. Clin Exp Rheumatol 1999; 17:37-8.
25. Kraan MC, Reece RJ, Smeets TJ, Veale DJ, Emery P, Tak PP. Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: Implications for pathogenesis and evaluation of treatment. Arthritis Rheumatol 2002; 46:2034-8.
26. Andersen M, Boesen M, Ellegaard K, Christensen R, Soderstrom K, Soe N, et al. Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross sectional study. Arthritis Res Ther 2014; 16:R107.
27. Scire CA, Epis O, Codullo V, Humby F, Morbini P, Manzo A, et al. Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. Arthritis Res Ther 2007; 9:R101.
28. Kelly S, Humby F, Filer A, Ng N, Di Cicco M, Hands RE, et al. Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients. Ann Rheum Dis 2015; 74:611-7.
29. Kaiser MJ, Hauzeur JP, Blacher S, Foidart JM, Deprez M, Rossknecht A, et al. Contrast-enhanced coded phase-inversion harmonic sonography of knee synovitis correlates with histological vessel density: 2 automated digital quantifications. J Rheumatol 2009; 36:1391-400.
30. Koski JM, Helle M. Ultrasound guided synovial biopsy using portal and forceps. Ann Rheum Dis 2005; 6:926-9.
31. Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, et al. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64:834-8.
32. Wijbrandts CA, Vergunst CE, Haringman JJ, Gerlag DM, Smeets TJ, Tak PP. Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum 2007; 56:3869-71.
33. Bresnihan B, Pontifex E, Thurlings RM, Vinkenoog M, El-Gabalawy H, Fearon U, et al. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J Rheumatol 2009; 36:1800-2.
34. Bresnihan B, Gerlag DM, Rooney T, Smeets TJ, Wijbrandts CA, Boyle D, et al. Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J Rheumatol 2007; 34:620-2.
35. Rooney T, Roux-Lombard P, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B. Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade. Ann Rheum Dis 2010; 69:706-14.
36. Ducreux J, Durez P, Galant C, Nzeusseu Toukap A, Van den Eynde B, Houssiau FA, et al. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol 2014; 66:15-23.
37. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT Filter 2.0. J Clin Epidemiol 2014; 67:745-53.